TY - JOUR
T1 - Deep-Learning–Based Screening and Ancillary Testing for Thyroid Cytopathology
AU - Dov, David
AU - Elliott Range, Danielle
AU - Cohen, Jonathan
AU - Bell, Jonathan
AU - Rocke, Daniel J.
AU - Kahmke, Russel R.
AU - Weiss-Meilik, Ahuva
AU - Lee, Walter T.
AU - Henao, Ricardo
AU - Carin, Lawrence
AU - Kovalsky, Shahar Z.
N1 - KAUST Repository Item: Exported on 2023-08-31
Acknowledgements: Supported by NIH award number 1R21CA268428-01 (D.D., D.E.R., D.J.R., and W.T.L.).
PY - 2023/8/21
Y1 - 2023/8/21
N2 - Thyroid cancer is the most common malignant endocrine tumor. The key test to assess preoperative risk of malignancy is cytologic evaluation of fine-needle aspiration biopsies (FNABs). The evaluation findings can often be indeterminate, leading to unnecessary surgery for benign post-surgical diagnoses. We have developed a deep-learning algorithm to analyze thyroid FNAB whole-slide images (WSIs). We show, on the largest reported data set of thyroid FNAB WSIs, clinical-grade performance in the screening of determinate cases and indications for its use as an ancillary test to disambiguate indeterminate cases. The algorithm screened and definitively classified 45.1% (130/288) of the WSIs as either benign or malignant with risk of malignancy rates of 2.7% and 94.7%, respectively. It reduced the number of indeterminate cases (N = 108) by reclassifying 21.3% (N = 23) as benign with a resultant risk of malignancy rate of 1.8%. Similar results were reproduced using a data set of consecutive FNABs collected during an entire calendar year, achieving clinically acceptable margins of error for thyroid FNAB classification.
AB - Thyroid cancer is the most common malignant endocrine tumor. The key test to assess preoperative risk of malignancy is cytologic evaluation of fine-needle aspiration biopsies (FNABs). The evaluation findings can often be indeterminate, leading to unnecessary surgery for benign post-surgical diagnoses. We have developed a deep-learning algorithm to analyze thyroid FNAB whole-slide images (WSIs). We show, on the largest reported data set of thyroid FNAB WSIs, clinical-grade performance in the screening of determinate cases and indications for its use as an ancillary test to disambiguate indeterminate cases. The algorithm screened and definitively classified 45.1% (130/288) of the WSIs as either benign or malignant with risk of malignancy rates of 2.7% and 94.7%, respectively. It reduced the number of indeterminate cases (N = 108) by reclassifying 21.3% (N = 23) as benign with a resultant risk of malignancy rate of 1.8%. Similar results were reproduced using a data set of consecutive FNABs collected during an entire calendar year, achieving clinically acceptable margins of error for thyroid FNAB classification.
UR - http://hdl.handle.net/10754/693881
UR - https://linkinghub.elsevier.com/retrieve/pii/S0002944023002031
UR - http://www.scopus.com/inward/record.url?scp=85168419769&partnerID=8YFLogxK
U2 - 10.1016/j.ajpath.2023.05.011
DO - 10.1016/j.ajpath.2023.05.011
M3 - Article
C2 - 37611969
SN - 0002-9440
VL - 193
SP - 1185
EP - 1194
JO - The American Journal of Pathology
JF - The American Journal of Pathology
IS - 9
ER -